Value of Thyroid Lymphatic Contrast-Enhanced Ultrasound in the Differential Diagnosis of Benign and Malignant Thyroid Nodules:A Prospective Single-Center Study

Lei CAI; Taohua GOU; Yan ZHANG

doi:10.3881/j.issn.1000-503X.17106

PDF(1199 KB)

Acta Academiae Medicinae Sinicae ›› 2026, Vol. 48 ›› Issue (4) : 653-659. DOI: 10.3881/j.issn.1000-503X.17106

Value of Thyroid Lymphatic Contrast-Enhanced Ultrasound in the Differential Diagnosis of Benign and Malignant Thyroid Nodules:A Prospective Single-Center Study

Lei CAI ¹^,² ,
Taohua GOU ¹^,² ,
Yan ZHANG ¹^,²

Author information +

History +

Abstract

Objective To explore the value of thyroid lymphatic contrast-enhanced ultrasound (LCEUS) in the differential diagnosis of benign and malignant thyroid nodules. Methods Patients who were suspected of having thyroid cancer by ultrasound and were planned to undergo puncture biopsy or surgery from November 2020 to June 2024 were prospectively enrolled.All the patients underwent conventional ultrasound and LCEUS before surgery.The enhancement characteristics within the nodules,around the nodules,and in the adjacent thyroid capsule were observed and recorded.With the pathological results as the gold standard,the above characteristics were compared between the benign and malignant groups. Results A total of 144 (37 benign and 107 malignant) nodules in 144 patients were finally included.The inter-observer consistency of each LCEUS index was excellent (Kappa value:0.84-0.93).Compared with benign nodules,malignant nodules were more likely to show non-enhancement (88.79% vs. 18.92%,P<0.001),an enlarged lesion area after contrast injection (60.75% vs. 18.92%,P<0.001),and irregular ring-shaped enhancement (49.53% vs. 10.81%,P<0.001).The sensitivity,specificity,and accuracy of LCEUS in diagnosing malignant nodules were 97.20%,75.68%,and 91.67% respectively.The area under the receiver operating characteristic curve was 0.864,higher than that (0.761) of conventional ultrasound (P<0.001). Conclusions By revealing the lymphatic perfusion characteristics inside and around the nodules,LCEUS shows excellent efficacy in the differential diagnosis of benign and malignant thyroid nodules.LCEUS exhibits significantly better specificity and overall diagnostic ability than conventional ultrasound,demonstrating important clinical application value.

Key words

thyroid nodule / ultrasound / contrast-enhanced ultrasound / lymphatic vessel

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Lei CAI , Taohua GOU , Yan ZHANG. Value of Thyroid Lymphatic Contrast-Enhanced Ultrasound in the Differential Diagnosis of Benign and Malignant Thyroid Nodules:A Prospective Single-Center Study[J]. Acta Academiae Medicinae Sinicae. 2026, 48(4): 653-659 https://doi.org/10.3881/j.issn.1000-503X.17106

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

[1]	Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.DOI:10.1089/thy.2015.0020. Cited in this article [1]

[2]	Durante C, Grani G, Lamartina L, et al. The diagnosis and management of thyroid nodules:a review[J]. JAMA, 2018, 319(9):914-924.DOI:10.1001/jama.2018.0898. Cited in this article [1]

[3]	Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging,Reporting and Data System (TI-RADS):white paper of the ACR TI-RADS Committee[J]. J Am Coll Radiol, 2017, 14(5):587-595.DOI:10.1016/j.jacr.2017.01.046. Cited in this article [1]

[4]	Persichetti A, Di Stasio E, Coccaro C, et al. Inter- and intraobserver agreement in the assessment of thyroid nodule ultrasound features and classification systems:a blinded multicenter study[J]. Thyroid, 2020, 30(2):237-242.DOI:10.1089/thy.2019.0360. Cited in this article [1]

[5]	Xu R, He Y, Xie X, et al. Diagnostic value of contrast-enhanced ultrasound for differentiating benign and malignant thyroid nodules:a systematic review and meta-analysis[J]. Ultrasound Med Biol, 2025, 51(11):1878-1887.DOI:10.1016/j.ultrasmedbio.2025.07.015. Cited in this article [1]

[6]	Choi YJ, Baek JH, Park HS, et al. A computer-aided diagnosis system using artificial intelligence for the diagnosis and characterization of thyroid nodules on ultrasound:initial clinical assessment[J]. Thyroid, 2017, 27(4):546-552.DOI:10.1089/thy.2016.0372. Cited in this article [1]

[7]	Cantisani V, Lodise P, Grazhdani H, et al. Ultrasound elastography in the evaluation of thyroid pathology:current status[J]. Eur J Radiol, 2014, 83(3):420-428.DOI:10.1016/j.ejrad.2013.05.008. Cited in this article [1]

[8]	Trimboli P, Guglielmi R, Monti S, et al. Ultrasound sensitivity for thyroid malignancy is increased by real-time elastography:a prospective multicenter study[J]. J Clin Endocrinol Metab, 2012, 97(12):4524-4530.DOI:10.1210/jc.2012-2951. Cited in this article [1]

[9]	Zhang Y, Lu YY, Li W, et al. Lymphatic contrast-enhanced US to improve the diagnosis of cervical lymph node metastasis from thyroid cancer[J]. Radiology, 2023, 307(4):e221265. DOI:10.1148/radiol.221265. Cited in this article [3]

[10]	Wei Y, Niu Y, Zhao ZL, et al. Effectiveness of lymphatic contrast enhanced ultrasound in the diagnosis of cervical lymph node metastasis from papillary thyroid carcinoma[J]. Sci Rep, 2022, 12(1):578.DOI:10.1038/s41598-021-04503-1. Cited in this article [2]

[11]	张艳, 赵佳航, 王冰, 等. 经淋巴管超声造影可提高甲状腺癌中央区转移淋巴结的检出率[J]. 南方医科大学学报, 2023, 43(2):219-224.DOI:10.12122/j.issn.1673-4254.2023.02.09. Cited in this article [1]

[12]	焦琼, 刘志艳. 第3版甲状腺细胞病理Bethesda报告系统解读[J]. 中华医学杂志, 2023, 103(41):3238-3244.DOI:10.3760/cma.j.cn112137-20230724-00079. Cited in this article [1]

[13]	Ringel MD, Sosa JA, Baloch Z, et al. 2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer[J]. Thyroid, 2025, 35(8):841-985.DOI:10.1177/10507256251363120. Cited in this article [1]

[14]	Hoang JK, Lee WK, Lee M, et al. US features of thyroid malignancy:pearls and pitfalls[J]. Radiographics, 2007, 27(3):847-865.DOI:10.1148/rg.273065038. Cited in this article [1]

[15]	Karaman S, Detmar M. Mechanisms of lymphatic metastasis[J]. J Clin Invest, 2014, 124(3):922-928.DOI:10.1172/JCI71606. Cited in this article [2]

[16]	Karnezis T, Shayan R, Caesar C, et al. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium[J]. Cancer Cell, 2012, 21(2):181-195.DOI:10.1016/j.ccr.2011.12.026. Cited in this article [1]

[17]	Choi Y, Park KJ, Ryu S, et al. Papillary thyroid carcinoma involving cervical neck lymph nodes:correlations with lymphangiogenesis and ultrasound features[J]. Endocr J, 2012, 59(10):941-948.DOI:10.1507/endocrj.ej12-0178. Cited in this article [1]

[18]	Hakala T, Sand J, Kellokumpu-Lehtinen PL, et al. Recurrent thyroid cancers have more peritumoural lymphatic vasculature than nonrecurrent thyroid cancers[J]. Eur J Clin Invest, 2014, 44(9):825-832.DOI:10.1111/eci.12301. Cited in this article [1]

[19]	Rezzola S, Sigmund EC, Halin C, et al. The lymphatic vasculature:an active and dynamic player in cancer progression[J]. Med Res Rev, 2022, 42(1):576-614.DOI:10.1002/med.21855. Cited in this article [1]

[20]	Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics[J]. Science, 2002, 296(5574):1883-1886.DOI:10.1126/science.1071420. Cited in this article [1]

[21]	Friedl P, Alexander S. Cancer invasion and the microenvironment:plasticity and reciprocity[J]. Cell, 2011, 147(5):992-1009.DOI:10.1016/j.cell.2011.11.016. Cited in this article [1]

[22]	Fujimoto N, Dieterich LC. Mechanisms and clinical significance of tumor lymphatic invasion[J]. Cells, 2021, 10(10):2585. DOI:10.3390/cells10102585. Cited in this article [1]

[23]	Baeyens N, Bandyopadhyay C, Coon BG, et al. Endothelial fluid shear stress sensing in vascular health and disease[J]. J Clin Invest, 2016, 126(3):821-828.DOI:10.1172/JCI83083. Cited in this article [1]

[24]	Hu Z, Zhao X, Wu Z, et al. Lymphatic vessel:origin,heterogeneity,biological functions,and therapeutic targets[J]. Signal Transduct Target Ther, 2024, 9(1):9.DOI:10.1038/s41392-023-01723-x. Cited in this article [1]

[25]	Kamaya A, Tahvildari AM, Patel BN, et al. Sonographic detection of extracapsular extension in papillary thyroid cancer[J]. J Ultrasound Med, 2015, 34(12):2225-2230.DOI:10.7863/ultra.15.02006. Cited in this article [1]

[26]	Zhang Y, Zhang X, Li J, et al. Contrast-enhanced ultrasound:a valuable modality for extracapsular extension assessment in papillary thyroid cancer[J]. Eur Radiol, 2021, 31(7):4568-4575.DOI:10.1007/s00330-020-07516-y. Cited in this article [2]